Tearwell, We Are a Unique Clinical Facility Dedicated Exclusively to The

Total Page:16

File Type:pdf, Size:1020Kb

Tearwell, We Are a Unique Clinical Facility Dedicated Exclusively to The Welcome to TearWell, We are a unique clinical facility dedicated exclusively to the diagnosis and treatment of Dry Eye Syndrome. TearWell is located within the FocalPoint at Crosstown Concourse, in Suite 264 on the second floor of the historic Crosstown Concourse building at 1350 Concourse Avenue. Free parking is readily available in front of building and a covered parking garage. Remember not to use any eye drops 4 hours prior to your appointment, and no gel, ointments or contact lenses the night before. Also, please do not wear any eye makeup or thick lotions/ moisturizing creams near the eyes to avoid interference with some of the testing we will be performing during your evaluation. Your appointment will last between 1.5 and 2 hours and you will not be dilated or your vision affected in any way. Please bring a list of all your eye drops and other dry eye therapies you are currently using or have tried in the past, as well as a list of all medications you are currently taking. Enclosed is some of the paperwork we would have you fill out at the time of your visit, feel free to complete it before hand to expedite the check in process. We look forward to seeing you; let us know if you have any questions or if there’s anything else we can do before your appointment. Thank you, Ramon Gomez Eyecare Concierge 901.252.3670 [email protected] Making Your TearWell Appointment You’ve suffered from dry eyes long enough. Take the first step in NORTH PARKWAY finding lasting relief at the TearWell Advanced Dry Eye Treatment Center in midtown Memphis. TearWell has quickly become the leading center in the Mid-South for the diagnosis and treatment of dry eye disease. CROSSTOWN GALLOWAY AVE CENTRAL CONCOURSE ATRIUM With the expertise of three of the leading optometric physicians ST N WATKINS CONCOURSE AVENUE who have devoted much of their career to treating dry eye PARKING disease, TearWell additionally benefits from its association GARAGE with one of the nation’s leading optometry colleges and clinical AUTUMN AVENUE N CLEVELAND ST GARLAND ST facilities. Schedule your appointment today to begin a consultation to ST N CLAYBROOK explore the best treatment option for you. The TearWell Advanced Dry Eye Treatment Center’s primary Call 901.252.3670 or email [email protected]. location is open Monday-Friday from 8:30am - 5pm in The You may also visit TearWell.com to learn more. FocalPoint at Crosstown Concourse operated by Southern College of Optometry in Memphis. Located in Suite 264 on the Here’s how to visit us: second floor of the historic Crosstown Concourse building at 1350 Concourse Avenue, TearWell offers exclusive treatment DRY EYE options dedicated to the treatment of Dry Eye Disease and Located in The FocalPoint at Crosstown Concourse, operated by dry eye symptoms. Southern College of Optometry, in Suite 264 on the second floor of the historic Crosstown Concourse building at 1350 Concourse TearWell is conveniently located with 15-25 minute drives Avenue. TearWell offers exclusive treatment options dedicated from Collierville, Cordova, Germantown, Southaven and West RELIEF to the treatment of Dry Eye Disease and dry eye symptoms. Memphis. We offer free, convenient parking located in the Crosstown Concourse parking garage. TearWell is conveniently located with 15-25 minute drives from Collierville, Cordova, Germantown, Southaven and West Memphis. We offer free, convenient parking located in the Crosstown Concourse parking garage. TM TM Financing Available 901.252.3670 tearwell.com | [email protected] 901.252.3670 tearwell.com | [email protected] facebook.com/ *Financing options for LipiFlow are available tearwellcenter @TearWellCenter 1350 Concourse Avenue at Crosstown Concourse through a third party financing company. Your Dry Eye Relief Starts Now Meet Your Doctors This information packet marks the start of finding the optimal relief Arizona. In 2013, Dr. Grant joined Southern College of Optometry, where Whitney Hauser, OD your dry eyes need. If dry eye relief has eluded you, TearWell brings she currently serves as a Clinical Instructor in The Eye Center. She is is the Clinic Development Consultant of TearWell you new opportunities to treat your symptoms. a member of the Tennessee Public Health Association, Tennessee Advanced Dry Eye Treatment Center. Dr. Hauser Association of Optometric Physicians and the American Optometric graduated from The University of Tennessee at TearWell offers the expertise of three optometric physicians Association. known for their research and extensive experience in treating Knoxville with a bachelor’s degree in Biology. She ocular surface disease, including dry eye disease. TearWell obtained her Doctor of Optometry at Southern College of Optometry (SCO) with the academic distinction magna cum Kristina Haworth, OD focuses exclusively on dry eye treatment. laud and completed her residency in Primary Care through SCO and the serves as Associate Professor at Southern College VA Medical Center in Memphis. She was also a member of Beta Sigma of Optometry. She served as Assistant Professor Kappa Honor Society. at The Ohio State University from 2011-2015. “TearWell has given me Dr. Hauser was in private practice for 10 years where her concentration While she was at Ohio State she earned both an new hope in finding the was Dry Eye and Ocular Surface Disease management as well as surgical M.S. and Ph.D. in Vision Science. Before that, she pre and post-operative care. She is an active member of the American earned her O.D. from Southern California College of Optometry. Prior help I needed.” Optometric Association, Ocular Nutrition Society, the Association for to her academic career, Dr. Haworth was part of an interdisciplinary Research in Vision and Ophthalmology, the World Congress of Optometry ophthalmology and optometry practice for 7 years before opening her and Women of Vision. Dr. Hauser is also an avid runner and fitness own solo optometric practice in California. It’s never been a better time to take advantage of the innovative, enthusiast. At Southern College of Optometry, Dr. Haworth supervises clinicians diagnostic testing that allows TearWell to create a customized in The Eye Center and at the University Eye Center. She also conducts treatment for each patient. TearWell is the first treatment center research related to findings from her Ph.D. dissertation. ® Rachel Grant, OD in the Memphis area to offer LipiFlow, the only FDA-approved Dr. Haworth holds optometry licenses in California, Ohio, Oregon and treatment for dry eye disease. graduated from the University of Victoria, in British Tennessee. She is a Fellow of the American Academy of Optometry. Columbia, Canada. She obtained her Doctor Her research focus is in ocular surface and dry eye conditions. She has At TearWell, we’re committed to understanding your needs. We of Optometry at Southern California College of published manuscripts in peer-reviewed journals and has presented look forward to meeting you and building a relationship as we Optometry (SCCO) at Marshall B. Ketchum University some of her findings at national annual meetings of the American explore the best treatment options available for you. and completed her residency training in Primary Academy of Optometry and the Association for Research in Vision and Care and Ocular Disease at Hu Hu Kam Memorial Hospital in Sacaton, Ophthalmology (ARVO) through scientific papers and posters. ACKNOWLEDGEMENT OF NOTICE OF PRIVACY PRACTICES I understand and acknowledge that in an attempt to protect the privacy of my identifi able health information, The Eye Center at Southern College of Optometry has established a Notice of Privacy Practices. This information details the use and disclosure of information contained in my personal medical records kept for the purposes of diagnosis, treatment, payment and health care operations. In accordance with HIPAA Regulations, a copy of the The Eye Center at Southern College of Optometry’s Notice of Privacy Practices has been made available to me while in the facility today. Should I choose to have a personal copy, one will be given to me at no charge. You can access this document at www.tec.sco.edu/patients/documents/GC-120A_notice_of_privacy_practices.pdf Patient Signature, if not a minor Date If patient is a minor, parent/legal guardian sign here Date If patient is a minor, agent for the Legal Custodian Date GC-120B 08/10 | Medical History Name: ___________________________________________________________ Date: _____________________ Email: ___________________________________________________________ Birth Date: ________________ Last Eye Exam (date): ________________ Last Eye Doctor (name): ____________________________________ Last Medical Exam (date): ____________ Last Medical Doctor (name): _________________________________ What is your eye problem/complaint today? Please describe this problem you are having as best as you can. ___________________________________________________________________________ ___________________________________________________________________________ Patient Ocular/Medical History Yes No Social History Yes No Glaucoma Do you smoke? Cataracts If YES, do you smoke every day? Macular Degeneration If NO, did you used to smoke? Eye Injury Do you use recreational drugs Retinal Disease Do you drink alcohol? Loss of Vision/Blindness Are you currently pregnant or nursing? Eye Turn/Strabismus What is your occupation? Lazy Eye/Amblyopia What are your hobbies? Eye Infection How many hours a day do you use a computer? Dry Eye What is your current
Recommended publications
  • WSPOS Worldwide Webinar 16: Amblyopia - How and When
    Answers to Audience Questions - WSPOS Worldwide Webinar 16: Amblyopia - How and When WWW 16 Panellists Anna Horwood Celeste Mansilla David Granet Krista Kelly Lionel Kowal Susan Cotter Yair Morad Anna Horwood (AH), Celeste Mansilla (CM), Krista Kelly (KK), Lionel Kowal (LK), Susan Cotter (SC), Yair Morad (YM) 1. How do you maintain attained iso visual acuity after successful amblyopia treatment? AH: Intermittent monitoring. If they have regressed previously, I might carry on very intermittent occlusion (an hour or two a week) until I was sure it was stable. CM: With gradual and controlled reduction of the treatment, for example: if the patient had 1 hour of patch per day, I leave it with 1 hour 3 times a week during a month. I do a check and if the visual acuity was maintained, I lower patches to 2 times a week. I keep checking and going down like this until I suspend the treatment. If at any time I detect worsening visual acuity, I return to the previous treatment. SC: Best way is attainment of normal binocular vision. I do not worry about ansiometropic amblyopes who have random dot stereopsis post-treatment. If have constant unilateral strabismus, I can do some limited part-time patching, decreasing patching dosage over time given no regression of VA. YM: repeat examination every 6 months. If I see regression, I will prescribe patching for 30 min a day. 2. How do you plan for very dense amblyopes? AH: I very rarely see them because, with screening, they are picked up early and usually do well.
    [Show full text]
  • Strabismus, Amblyopia & Leukocoria
    Strabismus, Amblyopia & Leukocoria [ Color index: Important | Notes: F1, F2 | Extra ] EDITING FILE ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Objectives: ➢ Not given. Done by: Jwaher Alharbi, Farrah Mendoza. ​ ​ Revised by: Rawan Aldhuwayhi ​ Resources: Slides + Notes + 434 team. ​ ​ NOTE: F1& F2 doctors are different, the doctor who gave F2 said she is in the exam committee so focus on her notes Amblyopia ● Definition Decrease in visual acuity of one eye without the presence of an organic cause that explains that decrease ​ ​ in visual acuity. He never complaints of anything and his family never noticed any abnormalities ​ ● Incidence The most common cause of visual loss under 20 years of life (2-4% of the general population) ● How? Cortical ignorance of one eye. This will end up having a lazy eye ​ ● binocular vision It is achieved by the use of the two eyes together so that separate and slightly dissimilar images arising in each eye are appreciated as a single image by the process of fusion. It’s importance 1. Stereopsis 2. Larger field If there is no coordination between the two eyes the person will have double vision and confusion so as a compensatory mechanism for double vision the brain will cause suppression. The visual pathway is a plastic system that continues to develop during childhood until around 6-9 years of age. During this time, the wiring between the retina and visual cortex is still developing. Any visual problem during this critical period, such as a refractive error or strabismus can mess up this developmental wiring, resulting in permanent visual loss that can't be fixed by any corrective means when they are older Why fusion may fail ? 1.
    [Show full text]
  • Amblyopia HANDOUT ACES
    AMBLYOPIA CORNEA PUPIL CATARACT IRIS LENS RETINA MACULA OPTIC NERVE The eye on the right is at risk for all three types of AMBLYOPIA. Rays of light enter the normal eye on the left, are bent by the cornea and the lens and are focused one the most precise part of the retina called the macula. Light entering the right eye is disrupted by a congenital cataract (deprivational amblyopia). Since the right eye is shorter than the left, light doesn't focus on the retina due to unequal far-sightedness(refractive amblyopia). Since the left eye is crossed (esotropia-type strabismus), incoming light fails to align on the macula (strabismic amblyopia). ye doctors and orthoptists want each child to grow frequently suppresses or "turns off" the brain image from up with the healthiest visual system possible. the non-dominant eye. Strabismic amblyopia can be E This goal requires the close cooperation of treated by combinations of drops, glasses, patching parents, pediatricians, primary doctors, optometrists, and/or eye muscle surgery. school nurses and health aids and the professionals who DETECTION: Within the first days after birth, deal with visually impaired babies. part of each baby's first physical exam is the "red reflex" an abnormality of which could indicate cataract or tumor. At birth, a normal infant has relatively poor vision in the range A part of routine pre-school pediatric check-ups is of 20/2000! Under normal conditions, the visual system improves so that observations of red reflex by photoscreen and Brückner 20/20 vision might be attained by school age and retained after age 10 years.
    [Show full text]
  • Human Amblyopia
    Human Amblyopia • “Lazy Eye” • Relatively common developmental visual disorder (~2%) • Reduced visual acuity in an otherwise healthy and properly corrected eye • Associated with interruption of normal early visual experience • Most common cause of vision loss in children • Well characterized behaviorally, not neurologically • Treated by patching in children Visual Deficits in Amblyopia • Reduced monoc. visual acuity - defining feature – Usually 20/30 - 20/60 • Impaired contrast sensitivity – Prominent at high spatial frequencies Contrast Sensitivity Sensitivity Contrast – Central visual field is generally most affected Spatial Frequency • Moderate deficits in object segmentation/recognition and spatial localization • Severe deficits in binocular interactions Subtypes of Amblyopia • Anisometropic – Unequal refractive error between the two eyes • Strabismic – Deviated eye that may or may not have unbalanced refraction • Deprivation – Congenital cataract; corneal opacity; eyelid masses Mechanisms of Amblyopia 1. Form deprivation . Sharp image is not formed at the retina 2. Abnormal binocular vision . Binocularity is often changed or lost in amblyopia Models of Amblyopia • Competition hypothesis originated with experiments in kittens in the 1960s by Hubel and Wiesel • Monocular deprivation of retinal input during ‘critical’ developmental periods leads to striking abnormalities in the physiology of visual cortical neurons • Binocular deprivation actually leads to less severe abnormalities • Amblyopia may be a form of activity-dependent deprivation,
    [Show full text]
  • Eye Care for EB Patients Debra.Org
    Eye Care for EB Patients Strategies to prevent blistering, scarring and vision loss DEBRA Care Conference 7.23.18 Vicki M. Chen, MD Assistant Professor of Ophthalmology New England Eye Center Tufts Medical Center / Floating Hospital for Children Boston, MA Financial Disclosures • None relevant Lecture Outline 1. What EB related problems can occur in the eye? 2. How can we prevent these problems? 3. Can we do more to reduce pain and vision loss? 4. Is research for EB related eye problems moving forward? What EB related problems can occur in the eye? • The most common problem is corneal abrasion • Cause is: dryness, injury, blister, erosion Missing epithelium… Infection Standard of care is to see patients every 2-3 days until abrasion is healed Why do abrasions occur in EB? • The surface of the eye is similar to skin • It has collagen VII and laminin-332 (5) which form an anchoring complex Corneal basement membrane ...similar to skin What other problems can occur? • Infected abrasion = ulcer • Scarring is common • Severe scars are white and block vision Infection Mild scar Severe scar Astigmatism can lead to amblyopia • Astigmatism causes distortion of images • In young children (under 10 years) astigmatism causes amblyopia • Amblyopia: poor vision development, can be permanent Left eye Right eye Vision does not develop in the eye with high astigmatism = Amblyopia Another common problem is blepharitis OIL NO OIL • Scarring closes oil glands, causes dryness • Dry eyes are more likely to erode • Inflammation due to mild bacterial infection • BKC: severe dryness causes corneal scarring and abnormal blood vessels to grow (seen in non-EB patients) Other eye problems… Tear drainage system bands of conjunctiva (symblepharon) watery eyes from clogged tear duct (obstruction) When do these problems start? JEB H + nH RDEB-HS • Typically JEB and RDEB patients are at higher risk for eye problems • Some start as early as 4-6 months of age • 30% of JEB and 10% of RDEB patients scar within first 10 years which is the critical time of vision development Graph from: J.D.
    [Show full text]
  • Keratoconus Into Focus
    SEPTEMBER 2019 # 37 In My View In Practice Profession Sitting Down With Musings of a prospective The amblyopia app making Why the fight for female Stefanie Schmickler: business- glaucoma patient screening accessible to all leadership is far from over minded, patient-focused 12 – 13 32 – 35 46 – 49 50 – 51 Bringing Keratoconus into Focus Sharpening up our response to this underdiagnosed condition 14– 26 NORTH AMERICA www.theophthalmologist.com FOR ROTATIONAL STABILITY, THERE’S NO COMPARISON1,2 1. Lee BS, Chang DF. Comparison of the rotational stability of two toric intraocular lenses in 1273 consecutive eyes. Ophthalmology. 2018;0:1-7. 2. Potvin R, et al. Toric intraoclar lens orientation and residual refractive astigmatism: an analysis. Clin Ophthalmol. 2016;10:1829-1836. Please see Important Product Information on the adjacent page. AcrySof®IQ Toric ASTIGMATISM-CORRECTING IOL © 2018 Novartis 7/18 US-TOR-18-E-1605 105064 US-TOR-18-E-1605 TO.indd 1 1/30/19 4:04 PM ACRYSOF® IQ TORIC IOL IMPORTANT PRODUCT INFORMATION CAUTION: Federal (USA) law restricts this device to the sale by or on the order of a physician. INDICATIONS: The AcrySof® IQ Toric posterior chamber intraocular lenses are Image intended for primary implantation in the capsular bag of the eye for visual correction of aphakia and pre-existing corneal astigmatism secondary to removal of a cataractous lens in of the adult patients with or without presbyopia, who desire improved uncorrected distance vision, reduction of residual refractive cylinder and Month increased spectacle independence for distance vision. WARNING/PRECAUTION: Careful preoperative evaluation and sound clinical judgment should be used by the surgeon to decide the risk/benefit ratio before implanting a lens in a patient with any of the conditions described in the Directions for Use labeling.
    [Show full text]
  • Presbyopia, Anisometropia, and Unilateral Amblyopia
    REFRACTIVE SURGERY COMPLEX CASE MANAGEMENT Section Editors: Karl G. Stonecipher, MD; Parag A. Majmudar, MD; and Stephen Coleman, MD Presbyopia, Anisometropia, and Unilateral Amblyopia BY MITCHELL A. JACKSON, MD; LOUIS E. PROBST, MD; AND JONATHAN H. TALAMO, MD CASE PRESENTATION A 45-year-old female nurse is interested in LASIK. She the AMO WaveScan WaveFront System (Abbott Medical does not wear glasses. She says there has always been a large Optics Inc.) for the patient’s right eye calculated a pre- difference in prescription between her eyes and that she scription at 4 mm of +2.20 -4.22 X 9 across a 5.75-mm rarely wore glasses in the past. Her UCVA is 20/200 OD, cor- pupillary diameter. This had a corresponding higher-order recting to 20/30 with +1.75 -4.25 X 180. Her UCVA is 20/40 aberration root mean square error of 0.20 µm. The OS, correcting to 20/15 with -0.75 -0.25 X 30. The patient is patient’s left eye had a calculated prescription of -0.56 right-handed, and her left eye is dominant. Central ultra- -0.21 X 31, also at 4 mm. The pupillary diameter of her left sound pachymetry measures 488 µm OD and 480 µm OS. eye was 5.25 mm, and the higher-order aberration root Figure 1 shows TMS4 (Tomey Corp.) topography of the mean square error was determined to be 0.17 µm patient’s right and left eyes, respectively. Both the (Figure 2). Klyce/Maeda and Smolek/Klyce Keratoconus Screening How would you counsel this patient regarding her suitability Systems are highlighted.
    [Show full text]
  • Strabismus, Amblyopia Management and Leukocoria 431Team
    Strabismus, Amblyopia Management and Leukocoria Done By: Tareq Mahmoud Aljurf Lecture mostly contains pictures, but the doctor gave a lot of additional info which we added here. Leukocoria Leukocoria is white opacity of the pupil, and it is a sign not a diagnosis. Causes will be presented going backwards through the eye structures: 1. Cataract Cataract: can be congenital or acquired, usually causes blurred vision and glare. Using the ophthalmoscope if you see nice red reflex on both eyes (pic on right.) unlikely to have any visual problems. Doctor’s notes: Congenital cataract is very important, because if you don’t treat it in the first months of life Irreversible amblyopia. For the brain to unify the 2 images both should have the same shape, size and clarity. If one is clear and the other is not brain gets confused can’t put them together suppresses image from the cataract eye. If this continues for 2,3 or 4 months amblyopia. For example: If the child presents with the problem at 1 year of age already too late, you can’t do anything. (Because amblyopia happens much earlier than 1yr) The eye is connected to the brain Retina and optic nerve regarded as parts of the CNS it’s a neurological problem difficult to reverse after 3 months of suppression. 2. Persistent hyperplastic primary vitreous PHPV is a congenital condition caused by failure of the normal regression of the primary vitreous. It is usually associated with unilateral vision loss Doctor’s notes: During embryology, blood vessels come from the optic nerve to nourish the lens, they usually disappear clear vitreous.
    [Show full text]
  • The Eyes in Marfan Syndrome
    THE EYES IN MARFAN SYNDROME Marfan syndrome and some related disorders can affect the eyes in many ways, causing dislocated lenses and other eye problems that can affect your sight. Except for dislocated lenses, these eye problems also occur in the general population, which is why doctors do not always realize they are caused by Marfan syndrome. It is important to know that, even though these problems occur in the general population, they are much more common in people who have Marfan syndrome. About 6 in 10 people with Marfan syndrome have dislocated lenses in one or both eyes. People with Marfan syndrome should see an ophthalmologist (a medical doctor who takes care of the eyes) to find out if they have any eye problems and learn how to care for their eyes. What are the common types of eye problems in people with Marfan syndrome? Some features of the eye related to Marfan syndrome that can cause vision problems include: Dislocated lenses About 6 in 10 people with Marfan syndrome have dislocated lenses in one or both eyes. This means the lens, located at the front of the eye, has slipped out of place because the connective tissue that holds the lens in place (called zonules) is weak. When this happens, the lens can slip in any direction—up, down, to the side, or back. It can slip a little or completely out of place, and anywhere in between. With the lens out of place, the eye can’t focus properly and vision is blurry. MARFAN.ORG | 800-8-MARFAN EXT.
    [Show full text]
  • Risk Factors in Amblyopia
    Eye (1990) 4, 787-793 Risk Factors in Amblyopia JOHAN SJOSTRAND and MATHS ABRAHAMSSON Goteborg, Sweden Summary Any intervention to prevent serious amblyopia is based on the knowledge about normal versus subnormal visual development. Our ability to predict with high degree of certainty which children will develop amblyopia will be dependant on the characteristics of various risk factors for initiating the development of squint or amblyopia. We have used longitudinal studies of population based cohorts of young children to define some of these risk factors such as refractive errors. Three hundred and ten children with an astigmatism:;:,:1. 0 D at one year of age were refracted yearly between the age one and four years. Astigmatism and anisometropia were found to be highly variable during infancy and early childhood. Longitudinal follow-up seems to be needed to separate the normal from the abnormal refraction development, which initiates the development of the amblyopia. Children with constant or increas­ ing astigmatism or anisometropia between one and four years were 'at risk'. In parallel we have studied important factors for successful treatment of amblyo­ pia. Based on these findings we conclude that a population screening at four years of age seems to be advantageous in Sweden in order detect and successfully treat most cases of amblyopia. Any intervention to prevent serious amblyo­ uations of the efficiencyof the screening pro­ pia has to be based on our knowledge about grams are few.! An abundant literature normal versus abnormal visual development. describes that the three main causes of I will specificallyfocus on the refractive errors amblyopia are strabismus, refractive errors as key factors for initiation of amblyopia.
    [Show full text]
  • Federal Register/Vol. 81, No. 131/Friday, July 8, 2016/Notices
    44680 Federal Register / Vol. 81, No. 131 / Friday, July 8, 2016 / Notices on to explain that because the current FMCSA Response FOR FURTHER INFORMATION CONTACT: exception remains in the FMCSRs (40 FMCSA responded to the question of Christine A. Hydock, Chief, Medical CFR 391.41(b)(12)(ii)), they recommend who is qualified to be a ME in the Programs Division, (202) 366–4001, guidelines be provided to MEs regarding National Registry of Certified Medical [email protected], FMCSA, the use of narcotics. Examiners final rule (77 FR 24106, April Department of Transportation, 1200 New Jersey Avenue SE., Room W64– FMCSA Response 20, 2012), and is not considering a change to the regulation in 49 CFR 113, Washington, DC 20590–0001. Although optional use of the 391.41 390.103, Eligibility requirements for Office hours are 8:30 a.m. to 5 p.m., e.t., Monday through Friday, except Federal CMV Driver Medication Form was medical examiner certification in this holidays. If you have questions introduced as a result of the MRB and notice. Therefore, these comments are regarding viewing or submitting MCSAC recommendations related to the outside the scope of this notice. material to the docket, contact Docket use of Schedule II medications by CMV Public Comments Invited: FMCSA Services, telephone (202) 366–9826. drivers, the recommendation was for requests that you comment on any SUPPLEMENTARY INFORMATION: FMCSA to develop a standardized form aspect of this information collection, to assist the certified ME when including: (1) Whether the proposed I. Electronic Access collection is necessary for FMCSA to reviewing prescription medications that You may see all the comments online have been disclosed during the history perform its functions, (2) the accuracy of the estimated burden, (3) ways for the through the Federal Document and physical examination for CMV Management System (FDMS) at http:// driver certification.
    [Show full text]
  • Case of the Month – November 2019
    Encino Santa Monica Valencia Thousand Oaks Century City (877) 3-RETINA Case of the Month – November 2019 Presented by Stavros N. Moysidis, MD A 47-year-old white male presented with complaints of decreased vision in his left eye (OS). He characterized the vision loss as sudden in onset, with a “warped” quality within his central visual axis and extending superiorly. He had a lifelong history of poor vision in the right eye (OD), from anisometropic amblyopia and felt his vision was stable in that eye. He reported a history of hypertension, well controlled on oral losartan. Visual acuity (VA) was 20/150 ph 20/80 in the OD and 20/60 phni in the OS. Intraocular pressures and anterior segment exam were normal. Dilated fundus exam revealed a focal, small retinal pigment epithelial detachment (PED) in the OD and a large PED with extensive subretinal fluid (SRF) in the OS (Figures 1A-B). Optical coherence tomography (OCT) conveyed fibrinous subretinal exudates overlying an oblong, flat PED OS (Figures 1D for OD; 1E-G for OS). Fluorescein angiography (FA) revealed hyperfluorescent pooling in the PED OD, contrasted with a hyperfluorescent smokestack pattern OS. Clinical Course: The findings and diagnosis of central serous chorioretinopathy (CSCR) were explained to the patient. The natural history of the disease and treatment options, including close monitoring, photodynamic therapy, oral eplerenone, oral rifampin, and intravitreal anti-VEGF therapy were discussed. He elected to proceed with oral eplerenone complemented by mindfulness-based stress reduction with a psychologist. Corticosteroid avoidance was recommended. He denied use of prescribed or over-the-counter steroids, including inhalers or creams.
    [Show full text]